How is the Talis Biomedical Corp today?

The Talis Biomedical Corp today is trading in the down by 0.00% at 1.41.

How has Talis Biomedical Corp performed historically?

The Talis Biomedical Corp is currently trading down 0.00% on an intraday basis in the past week the index fell None%. The index has been down -25.79% in the past quarter and fell -84.61% in the past year. You can view this in the overview section.

What is Talis Biomedical Corp Annual Revenue?

Talis Biomedical Corp Annual Revenue fell 59.69%, in the last year to $0.41 M. Its sector's average revenue growth for the last fiscal year was 9.85%.

What is Talis Biomedical Corp Annual Net Profit?

Talis Biomedical Corp Annual Net Profit rose 27.74% in the last year to $62.01 M. Its sector's average net profit growth for the last fiscal year was 6.79%.

What is Talis Biomedical Corp Price to Earning Ratio?

Talis Biomedical Corp Price to Earning Ratio is -0.05, which is negative.

What is Talis Biomedical Corp Stock Price?

Talis Biomedical Corp Stock Price fell 84.61% and underperformed its sector by 94.09% in the past year.

What is Talis Biomedical Corp Quarterly Net profit?

Talis Biomedical Corp Quarterly Net profit rose 41.14% YoY to $8.85 M. Its sector's average net profit growth YoY for the quarter was 43.18%.

What is Talis Biomedical Corp Debt to Equity Ratio?

Talis Biomedical Corp Debt to Equity Ratio of 0.28 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Talis Biomedical Corp Return on Equity(ROE)?

Talis Biomedical Corp Return on Equity(ROE) for the last financial year was -63.32%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Talis Biomedical Corp Mutual Fund Holding?

Talis Biomedical Corp Mutual Fund Holding decreased by 0.01% in the last quarter to 0.92.

What is Talis Biomedical Corp Institutional Holding?

Talis Biomedical Corp Institutional Holding decreased by 0% in the last quarter to 9.06.

Talis Biomedical Corp XNAS: TLIS

Talis Biomedical Corp Live Share Price Today, Share Analysis and Chart

Name: Talis Biomedical Corp: Is Infosys Ltd. worth buying?
Item: Talis Biomedical Corp
Rating: 0.90750
Author: Trendlyne DVM scores

about

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to e...

1.41 0.00 (0.00%)

85.20% Fall from 52W High

60 XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Talis Biomedical Corp is on 26 May 2025 for the purpose of Talis Biomedical Corp First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

19.5 / 100

Technically Bearish

16.8 / 100

No estimates available

Talis Biomedical Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Talis Biomedical Corp Live Share Price Today, Share Analysis and Chart

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to e...

85.20% Fall from 52W High

SWOT Analysis

Talis Biomedical Corp Live Price Chart

Talis Biomedical Corp FAQ

How is Talis Biomedical Corp today?

Talis Biomedical Corp today is trading in the red, and is down by 0.00% at 1.41.

How has Talis Biomedical Corp performed historically?

Talis Biomedical Corp is currently trading down 0.00% on an intraday basis. In the past week the stock fell None%. stock has been down -25.79% in the past quarter and fell -84.61% in the past year. You can view this in the overview section.